Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKYX Platforms Corp. Director's Dealing 2024

Sep 14, 2024

33953_dirs_2024-09-13_87315c66-799f-4d5f-be1e-0005bae9a679.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SKYX Platforms Corp. (SKYX)
CIK: 0001598981
Period of Report: 2024-09-12

Reporting Person: SOKOLOW LEONARD J (Director, Co-Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-12 Common Stock, no par value G 18000 Disposed 741220 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.6 2025-11-15 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $3 2027-04-19 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $4 2027-04-19 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $12 2025-01-01 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12 2025-12-31 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12 2026-12-31 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12.34 2027-03-11 Common Stock, no par value (17500) 17500 Direct
Stock Option (right to buy) $3.28 2028-04-05 Common Stock, no par value (17500) 17500 Direct
Stock Option (right to buy) $1.58 2028-09-12 Common Stock, no par value (450000) 450000 Direct
Warrant (right to buy) $9.8 2024-10-26 Common Stock, no par value (1088) 1088 Direct
Warrant (right to buy) $9.8 2024-11-29 Common Stock, no par value (3375) 3375 Direct
Warrant (right to buy) $9.8 2024-12-22 Common Stock, no par value (19827) 19827 Direct
Subordinated Convertible Promissory Note $3 2025-05-16 Common Stock, no par value () Direct

Footnotes

F1: Exercisable at any time on or prior to the expiration date at the holder's discretion at the adjusted exercise price of $9.80 per share, subject to adjustment provisions (including certain anti-dilution provisions).

F2: The principal amount, plus any accrued and unpaid interest, is convertible into shares of common stock at any time on or prior to the maturity date at the holder's discretion at the conversion price of $3.00 per share.

F3: Represents the principal amount of the convertible note and excludes interest that may accrue. Beginning January 1, 2024, the note accrues interest at a rate of 10.0% per annum, which is payable annually, in cash or common stock, at the holder's discretion. Prior to such date, the note accrued interest at a rate of 6.0% per annum.

F4: Options vest over 3.5 years as follows, subject to continued employment through the vesting date: 120,000 vested on September 12, 2023; 300,000 vest in six semi-annual installments of 50,000, beginning on March 12, 2024; and 30,000 vest on March 12, 2027.

F5: Includes 230,000 restricted stock units, which will vest as follows, subject to continued employment through the vesting date: 200,000 in four semi-annual installments of 50,000 beginning on March 12, 2025 and 30,000 on March 12, 2027.